Ranitidine Recall: Alternative Treatments for Heartburn

A Michigan Medicine gastroenterologist discusses the recent recall of ranitidine, or Zantac, and shares treatment options and tips for individuals living with heartburn.

5:00 AM

Author | Jina Sawani

 

Recently, the Food and Drug Administration requested a manufacturer's market withdrawal of ranitidine, or Zantac, which many individuals take to treat heartburn. This recall means that all ranitidine products have been removed from the market and will no longer be available for new or existing prescriptions or over-the-counter use.

The FDA found that the drug may contain a contaminant known as N-nitrosodimethylamine, or NDMA, that is associated with pancreatic cancer, posing risks to patients.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher. 

Michigan Medicine's William Chey, M.D., a gastroenterologist and professor of medicine and nutrition sciences, is an expert when it comes to treating heartburn. In this video, he discusses the recent ranitidine recall and offers tips for treating the condition now that Zantac is no longer an option.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

 

More Articles About: Health Management Reflux or GERD Pharmacy Digestive (GI) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Heartburn image
Health Lab
Feeling the Burn? Advice on Handling Heartburn During the Holidays
Heartburn can appear as an unwanted holiday guest. Here, Dr. William Chey shares tips for managing heartburn during any season.
 Kid holding pumpkin bowl of candy in skeleton costume
Health Lab
Is chocolate safe for people with IBS?
With Halloween and the holiday season right around the corner, people with IBS may want to reconsider choosing to eat chocolate.
 prescription pad blue yellow sketch
Health Lab
Risk of clots, stroke from incorrect blood thinner dosing reduced using online dashboard
Doctors and pharmacists treating people with blood thinners can now reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system.
 bacteria blue yellow
Health Lab
New guideline for Helicobacter pylori includes change to primary treatment recommendation
The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) Infection. 
 teal background of three people thinking three different things regarding money and health
Health Lab
As election approaches, national poll shows which health topics concern older adults most
Health care costs of different kinds, and financial scams, are top of mind for people age 50 and older going into the November election.
 person at counter with medicine brown bottle and pills
Health Lab
Most blood thinner dosing problems happen after initial prescription
More than two-thirds of those people take a type of blood thinner called a direct oral anticoagulant. These DOACs, such as rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), are under- or over-prescribed in up to one in eight patents. These prescribing issues can have life-threatening consequences, and they most often occur after a provider writes the initial prescription, according to a study led by Michigan Medicine.